The Federal Trade Commission is currently accepting public comments on an application by Service Corporation International (SCI) to sell certain funeral and cemetery assets, as required under the FTC’s April 2014 order settling charges that SCI’s acquisition of Stewart Enterprises, Inc. would likely be anticompetitive. In total, the order requires the combined SCI/Stewart to divest […]
Tag Archives: Bureau of Competition Competition
FTC Approves Two SCI Applications to Divest Funeral Home and Cemetery Assets in South Carolina and Maryland
Following a public comment period, the Federal Trade Commission has approved two applications by Service Corporation International (SCI) to divest certain funeral and cemetery assets, as required under the FTC’s order settling charges that SCI’s acquisition of Stewart Enterprises, Inc. would likely be anticompetitive. In total, the order requires the combined SCI/Stewart to divest 53 […]
FTC Puts Conditions on Valeant Pharmaceuticals’ Proposed Acquisition of Precision Dermatology
Valeant Pharmaceuticals International, Inc. and Precision Dermatology, Inc. have agreed to sell or relinquish rights to Precision’s branded single-agent topical tretinoins and generic Retin-A, common acne treatments, to settle Federal Trade Commission charges that Valeant’s proposed $475 million acquisition of Precision would likely be anticompetitive. This action is part of the FTC’s ongoing effort to […]
FTC Requests Public Comments on SCI’s Application to Approve Sale of Tennessee Cemetery and Funeral Assets to Heritage Family Funeral Services, Inc., and Heritage Family Cemetery, Inc.
The Federal Trade Commission is currently accepting public comments on an application by Service Corporation International (SCI) to sell certain funeral and cemetery assets, as required under the FTC’s April 2014 order settling charges that SCI’s acquisition of Stewart Enterprises, Inc. would likely be anticompetitive. In total, the order requires the combined SCI/Stewart to divest […]
FTC Puts Conditions on Actavis plc’s Acquisition of Forest Laboratories, Inc.
Pharmaceutical companies Actavis plc and Forest Laboratories, Inc. have agreed to sell or relinquish their rights to four generic pharmaceuticals that treat hypertension, angina, cirrhosis, and prevent seizures to settle Federal Trade Commission charges that Actavis’s acquisition of Forest likely would be anticompetitive. According to the FTC’s complaint, Actavis’s acquisition of Forest, as originally proposed, […]
FTC Approves Final Order Settling Charges That Akorn Enterprises’ Acquisition of Hi-Tech Pharmacal Was Anticompetitive
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn Enterprises’ $640 million acquisition of Hi-Tech Pharmacal, Inc. was anticompetitive and would lead to higher prices for consumers in several current and future generic drug markets. According to the FTC’s complaint, originally announced in April 2014, the […]
FTC Amicus Brief: Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition
The Federal Trade Commission has filed an amicus brief in the U.S. District Court for the District of New Jersey explaining that a brand name drug manufacturer’s improper use of a restricted drug distribution program to impede generic competition could violate the antitrust laws. The FTC filed the brief in the matter of Mylan Pharms., […]
FTC Approves Final Order Settling Charges That Ardagh’s Proposed Acquisition of Saint-Gobain Would Be Anticompetitive; Approves Ardagh’s Application to Sell Six Glass Plants and Related Assets
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Ardagh Group SA’s $1.7 billion proposed acquisition of Saint-Gobain Containers, Inc. would likely harm competition in the markets for glass containers sold to beer brewers and spirits distillers. The FTC’s administrative complaint, issued in July 2013, alleged that […]
FTC Requests Public Comments on SCI’s Application to Approve Sale of Funeral Home Assets in Alabama to Legacy Funeral Holdings of Alabama LLC
The Federal Trade Commission is currently accepting public comments on an application by Service Corporation International (SCI) to sell certain funeral and cemetery assets, as required under the FTC’s December 2013 proposed order settling charges that SCI’s acquisition of Stewart Enterprises, Inc. would be anticompetitive. In total, the proposed order requires the combined SCI/Stewart to […]
FTC Approves Franchise Services of North America’s Application to Sell Certain Advantage Rent a Car Locations to Hertz and Avis Budget Group
Following a public comment period, the Federal Trade Commission has approved an application submitted by Franchise Services of North America, Inc. (FSNA) regarding the sale of 22 former Advantage Rent A Car locations, to Hertz Global Holdings, Inc. (Hertz) and Avis Budget Group (Avis). FSNA acquired the locations under a 2012 FTC settlement to resolve […]